Onconova Therapeutics Inc

NASDAQ:ONTX   3:59:33 PM EDT
0.81
-0.04 (-4.66%)
7:52:50 PM EDT: $0.80 -0.01 (-1.28%)
Earnings Announcements

Onconova Therapeutics Inc Says Cash And Cash Equivalents As Of Sept. 30, 2022 Were $42.6 Million Compared With $55.1 Million As Of December 31, 2021

Published: 11/14/2022 22:28 GMT
Onconova Therapeutics Inc (ONTX) - Onconova Therapeutics Inc - Cash and Cash Equivalents As of Sept.
30, 2022 Were $42.6 Million Compared With $55.1 Million As of December 31, 2021.
Onconova Therapeutics Inc - Cash & Cash Equivalents Will Be Sufficient to Fund Ongoing Clinical Trials & Business Operations Into 2024.
Onconova Therapeutics Inc - Net Loss for the Third Quarter of 2022 Was $5.4 Million, Or $0.26 per Share on 20.9 Million Weighted Shared Outstanding.
Further Company Coverage: Ontxo ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0.08 Million
Adjusted EPS is expected to be -$0.28

Next Quarter Revenue Guidance is expected to be $0.1 Million
Next Quarter EPS Guidance is expected to be -$0.30

More details on our Analysts Page.